MeSH term
Frequency | Condition_Probility | Animals | 8 | 0.0 |
Base Sequence | 10 | 0.0 |
*Genes, Immunoglobulin | 3 | 1.0 |
Humans | 48 | 0.0 |
Immunoglobulins, Heavy-Chain/genetics | 2 | 1.0 |
Leukemia, B-Cell, Chronic/*genetics | 3 | 7.0 |
Mice | 4 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Mutation | 2 | 0.0 |
Translocation, Genetic | 2 | 0.0 |
Alleles | 5 | 0.0 |
Case-Control Studies | 5 | 0.0 |
Chromosomes, Human, Pair 17 | 2 | 0.0 |
Chromosomes, Human, Pair 19 | 4 | 2.0 |
Chromosomes, Human, Pair 6 | 2 | 1.0 |
Cleft Lip/*genetics | 8 | 12.0 |
Cleft Palate/*genetics | 7 | 9.0 |
Genetic Markers | 7 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Karyotyping | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Female | 18 | 0.0 |
Protein Binding | 4 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
*Gene Rearrangement | 3 | 1.0 |
Middle Aged | 7 | 0.0 |
Pregnancy | 3 | 0.0 |
Proto-Oncogene Proteins/*genetics | 11 | 1.0 |
*Translocation, Genetic | 10 | 1.0 |
Adolescent | 2 | 0.0 |
Adult | 6 | 0.0 |
Aged | 7 | 0.0 |
Chromosome Mapping | 7 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Lymphoma, B-Cell/*genetics | 4 | 5.0 |
Male | 17 | 0.0 |
Chi-Square Distribution | 2 | 0.0 |
Genotype | 6 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Logistic Models | 2 | 0.0 |
Monte Carlo Method | 2 | 2.0 |
Risk Factors | 2 | 0.0 |
Cell Line | 4 | 0.0 |
Comparative Study | 4 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
DNA/metabolism | 2 | 0.0 |
NF-kappa B/*metabolism | 4 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Chromosomes, Human, Pair 19/*genetics | 4 | 4.0 |
*Linkage (Genetics) | 3 | 0.0 |
Pedigree | 4 | 0.0 |
Proto-Oncogene Proteins/genetics | 4 | 0.0 |
Proto-Oncogenes | 2 | 1.0 |
Cleft Lip/epidemiology/*genetics | 3 | 37.0 |
Cleft Palate/epidemiology/*genetics | 3 | 37.0 |
Linkage (Genetics) | 7 | 0.0 |
European Continental Ancestry Group/genetics | 2 | 0.0 |
Exons | 3 | 0.0 |
Introns | 3 | 0.0 |
*Linkage Disequilibrium | 2 | 1.0 |
*Mutation | 3 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
DNA/*metabolism | 3 | 0.0 |
Dimerization | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Receptors, Retinoic Acid/genetics | 2 | 2.0 |
Transforming Growth Factor alpha/genetics | 3 | 11.0 |
Blotting, Southern | 2 | 0.0 |
Chromosomes, Human, Pair 14/*genetics | 2 | 2.0 |
Cloning, Molecular | 2 | 0.0 |
Child | 3 | 0.0 |
DNA, Neoplasm/genetics | 5 | 0.0 |
Protein-Tyrosine Kinase/genetics | 2 | 1.0 |
*Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 14 | 2 | 1.0 |
*Chromosomes, Human, Pair 8 | 2 | 0.0 |
Genes, myc | 2 | 0.0 |
Leukemia, B-Cell/*genetics | 3 | 33.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
Retrospective Studies | 2 | 0.0 |
*Chromosomes, Human, Pair 19 | 5 | 1.0 |
Linkage Disequilibrium | 2 | 0.0 |
Lod Score | 4 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Lymphoma, B-Cell/genetics/*pathology | 2 | 20.0 |
Gene Frequency | 3 | 0.0 |
Chromosome Banding | 2 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
*Proto-Oncogenes | 5 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Chromosomes, Human, Pair 14 | 2 | 1.0 |
Restriction Mapping | 2 | 0.0 |
Transfection | 2 | 0.0 |
RNA Splicing | 2 | 0.0 |
